Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
出版年份 2017 全文链接
标题
Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
作者
关键词
-
出版物
Biomed Research International
Volume 2017, Issue -, Pages 1-12
出版商
Hindawi Limited
发表日期
2017-02-24
DOI
10.1155/2017/9729107
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
- (2015) Mei Yang et al. PLoS One
- Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease
- (2014) David E. Amacher BIOMARKERS
- Diagnostic Accuracy Measures
- (2014) Paolo Eusebi CEREBROVASCULAR DISEASES
- Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients
- (2014) Alexander Wree et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
- (2013) Yun Shen et al. Cardiovascular Diabetology
- Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis
- (2013) Jing Chen et al. HEPATOLOGY RESEARCH
- Circulating Levels of FGF-21 in Obese Youth: Associations With Liver Fat Content and Markers of Liver Damage
- (2013) Cosimo Giannini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
- (2013) Anna Alisi et al. PLoS One
- Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
- (2013) Nikola Panic et al. PLoS One
- Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers
- (2012) J. Shen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis
- (2012) Yusuf Yilmaz et al. CLINICA CHIMICA ACTA
- Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives
- (2012) Y. C. Woo et al. CLINICAL ENDOCRINOLOGY
- Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
- (2012) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
- (2012) Jiayun Shen et al. JOURNAL OF HEPATOLOGY
- High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
- (2012) Huating Li et al. JOURNAL OF HEPATOLOGY
- Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
- (2011) H. Yu et al. CLINICAL CHEMISTRY
- Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
- (2011) Srinivasan Dasarathy et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis
- (2011) Diana Joka et al. HEPATOLOGY
- Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
- (2011) Hongmei Yan et al. PLoS One
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
- (2010) Alexander Wree et al. DIGESTION
- Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- Serum Apoptotic Caspase Activity in Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease
- (2010) George V. Papatheodoridis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis
- (2010) Pamela Valva et al. JOURNAL OF MEDICAL VIROLOGY
- A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
- (2010) Zobair M. Younossi et al. OBESITY SURGERY
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation
- (2009) Giovanni Musso et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease
- (2009) Raza Malik et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
- (2008) Dima L. Diab et al. Clinical Gastroenterology and Hepatology
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- A “Biomarker Biopsy” for the Diagnosis of NASH: Promises from CK-18 Fragments
- (2008) Yusuf Yilmaz et al. OBESITY SURGERY
- A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
- (2008) Zobair M. Younossi et al. OBESITY SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now